Ahrens Investment Partners’s Eli Lilly LLY Stock Holding History

Ahrens Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$364K	Buy	1,060 +1	+0.1%	+$337	0.18%	93
2022 Q4	$388K	Buy	1,059 +30	+3%	+$10.6K	0.18%	99
2022 Q3	$333K	Hold	1,029	–	–	0.18%	103
2022 Q2	$334K	Hold	1,029	–	–	0.15%	114
2022 Q1	$295K	Buy	1,029 +1	+0.1%	+$257	0.09%	146
2021 Q4	$284K	Hold	1,028	–	–	0.13%	149
2021 Q3	$238K	Sell	1,028 -11	-1%	-$2.71K	0.11%	176
2021 Q2	$238K	Buy	+1,039	New	+$209K	0.11%	196
2020 Q3	–	Sell	-1,438	Closed	-$236K	–	190
2020 Q2	$236K	Buy	+1,438	New	+$221K	0.14%	125

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ahrens Investment Partners's LLY Position: Q1 2023 in Review

Ahrens Investment Partners increased its Eli Lilly (LLY) stake by 0.09% in Q1 2023, buying an estimated $337 and bringing the position to 1,060 shares worth $364K. The position accounts for 0.18% of the portfolio, ranked #93.

Ahrens Investment Partners first reported a position in LLY in Q2 2020 and has held it in 9 quarters since. The position peaked at $388K in Q4 2022. 2,615 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

Ahrens Investment Partners held 1,060 shares of Eli Lilly worth $364K as of Q1 2023.
Ahrens Investment Partners bought 1 Eli Lilly share in Q1 2023, an estimated $337.
Eli Lilly made up 0.18% of Ahrens Investment Partners's portfolio in Q1 2023, its #93 holding.
Ahrens Investment Partners first reported a position in Eli Lilly in Q2 2020 and has held it in 9 quarters since.
Ahrens Investment Partners's Eli Lilly position peaked at $388K in Q4 2022.
2,615 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.